HIF-1α-KD tumors injected with recombinant Cyr61 showed increased vascular permeability, which is in agreement with Cyr61 as an inducer of aberrant tumor angiogenesis associated with nonfunctional leaky vessels and hypoxia. The gene discussed is HIF1A; the disease is neoplasm.